Joint Canadian Association of Gastroenterology and Crohn’s Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease

Detalles Bibliográficos
Autores principales: Moayyedi, Paul, Benchimol, Eric I, Armstrong, David, Yuan, Cathy, Fernandes, Aida, Leontiadis, Grigorios I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985688/
https://www.ncbi.nlm.nih.gov/pubmed/32010877
http://dx.doi.org/10.1093/jcag/gwz035
_version_ 1783491857950441472
author Moayyedi, Paul
Benchimol, Eric I
Armstrong, David
Yuan, Cathy
Fernandes, Aida
Leontiadis, Grigorios I
author_facet Moayyedi, Paul
Benchimol, Eric I
Armstrong, David
Yuan, Cathy
Fernandes, Aida
Leontiadis, Grigorios I
author_sort Moayyedi, Paul
collection PubMed
description
format Online
Article
Text
id pubmed-6985688
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-69856882020-01-31 Joint Canadian Association of Gastroenterology and Crohn’s Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease Moayyedi, Paul Benchimol, Eric I Armstrong, David Yuan, Cathy Fernandes, Aida Leontiadis, Grigorios I J Can Assoc Gastroenterol Original Articles Oxford University Press 2019-11-08 /pmc/articles/PMC6985688/ /pubmed/32010877 http://dx.doi.org/10.1093/jcag/gwz035 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the Canadian Association of Gastroenterology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Moayyedi, Paul
Benchimol, Eric I
Armstrong, David
Yuan, Cathy
Fernandes, Aida
Leontiadis, Grigorios I
Joint Canadian Association of Gastroenterology and Crohn’s Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease
title Joint Canadian Association of Gastroenterology and Crohn’s Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease
title_full Joint Canadian Association of Gastroenterology and Crohn’s Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease
title_fullStr Joint Canadian Association of Gastroenterology and Crohn’s Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease
title_full_unstemmed Joint Canadian Association of Gastroenterology and Crohn’s Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease
title_short Joint Canadian Association of Gastroenterology and Crohn’s Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease
title_sort joint canadian association of gastroenterology and crohn’s colitis canada position statement on biosimilars for the treatment of inflammatory bowel disease
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985688/
https://www.ncbi.nlm.nih.gov/pubmed/32010877
http://dx.doi.org/10.1093/jcag/gwz035
work_keys_str_mv AT moayyedipaul jointcanadianassociationofgastroenterologyandcrohnscolitiscanadapositionstatementonbiosimilarsforthetreatmentofinflammatoryboweldisease
AT benchimolerici jointcanadianassociationofgastroenterologyandcrohnscolitiscanadapositionstatementonbiosimilarsforthetreatmentofinflammatoryboweldisease
AT armstrongdavid jointcanadianassociationofgastroenterologyandcrohnscolitiscanadapositionstatementonbiosimilarsforthetreatmentofinflammatoryboweldisease
AT yuancathy jointcanadianassociationofgastroenterologyandcrohnscolitiscanadapositionstatementonbiosimilarsforthetreatmentofinflammatoryboweldisease
AT fernandesaida jointcanadianassociationofgastroenterologyandcrohnscolitiscanadapositionstatementonbiosimilarsforthetreatmentofinflammatoryboweldisease
AT leontiadisgrigoriosi jointcanadianassociationofgastroenterologyandcrohnscolitiscanadapositionstatementonbiosimilarsforthetreatmentofinflammatoryboweldisease

Ejemplares similares